NEW YORK, May 22 – Signaling its effort to expand into the burgeoning proteomics arena, Agilent Technologies said Tuesday it has agreed to partner with MDS Proteomics to develop laboratory technology for identifying and analyzing proteins more quickly. 

The joint effort will draw on Agilent’s expertise in separation science and liquid chromatography, and MDS Proteomics’ experience in mass spectrometry, bioinformatics, and the study of protein pathways.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.